Pabst Steinmetz Foundation is accepting applications for its 2027 Grant Application Cycle. Applications may be submitted from May 1 through September 15, 2026. The Foundation’s current public materials do not state an exact closing clock time or time zone, so Atlas does not infer one.
Eligible applicants are U.S. 501(c)(3) organizations. The Foundation states that organizations whose work connects to programs, organizations or institutions associated with Florida are of particular interest. It is especially interested in organizations working at the intersection of the arts with wellness, education, medicine and technology. Applicants are asked to demonstrate innovation, potential for replication or scale, community impact, collaboration where appropriate, sustainability and impact on local and regional communities, primarily in Florida. Single-year and multi-year requests are accepted.
The current official public materials do not publish a fixed 2027 award ceiling or total funding pool and do not state a mandatory match or cost-share requirement. The application is submitted through the Foundation’s online application process. Public guidance does not enumerate every required upload or attachment, so the live application portal controls those requirements.
Atlas fit: Atlas Opportunity Score 78/100. N9+ Fit Score 32/100, conditional. A legitimate role for the Nonagon N9+ device and platform would have to be a narrow, applicant-defined supporting technology component inside a qualifying arts, wellness, medicine or technology initiative. The Foundation does not present this as a medical-device, telehealth or clinical-equipment grant, so Atlas does not force a device fit. QC Healthcare fit is approximately 25/100 conditional. Dr. Miltie, LLC is not a direct eligible applicant because the applicant must be a 501(c)(3) organization.
Outreach status: publication and tracking only. Because the Foundation does not publish an exact deadline time and fewer than 48 hours may remain, Atlas will not initiate new cold applicant outreach for this cycle.